Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M222,398Revenue (TTM) $M50,992Net Margin (%)14.9Altman Z-Score2.6
Enterprise Value $M242,630EPS (TTM) $1.2Operating Margin %25.0Piotroski F-Score6
P/E(ttm)30.0Beneish M-Score-2.6Pre-tax Margin (%)18.5Higher ROA y-yN
Price/Book3.510-y EBITDA Growth Rate %2.6Quick Ratio1.2Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %0.6Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow16.4y-y EBITDA Growth Rate %-14.6ROA % (ttm)4.6Higher Current Ratio y-yN
Dividend Yield %3.2PEG50.2ROE % (ttm)11.6Less Shares Outstanding y-yY
Payout Ratio %93.0Shares Outstanding M6,065ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFET Rowe Price Equity Income Fund 2016-06-30 Reduce-0.11%$29.64 - $35.31
($33.58)
$ 36.679%Reduce -5.36%13,941,800
PFELeon Cooperman 2016-03-31 Sold Out -0.91%$28.56 - $32.28
($30.14)
$ 36.6722%Sold Out0
PFEKahn Brothers 2016-03-31 Reduce-0.73%$28.56 - $32.28
($30.14)
$ 36.6722%Reduce -8.11%1,442,543
PFEJoel Greenblatt 2016-03-31 Buy 0.52%$28.56 - $32.28
($30.14)
$ 36.6722%New holding1,577,263
PFENWQ Managers 2016-03-31 Add0.25%$28.56 - $32.28
($30.14)
$ 36.6722%Add 28.00%2,518,601
PFEJohn Paulson 2016-03-31 Add0.17%$28.56 - $32.28
($30.14)
$ 36.6722%Add 117.81%1,378,100
PFEVanguard Health Care Fund 2016-03-31 Reduce-0.1%$28.56 - $32.28
($30.14)
$ 36.6722%Reduce -18.09%7,267,526
PFECharles Brandes 2016-03-31 Reduce-0.05%$28.56 - $32.28
($30.14)
$ 36.6722%Reduce -1.83%5,536,325
PFEDavid Tepper 2016-03-31 Add0.05%$28.56 - $32.28
($30.14)
$ 36.6722%Add 4.15%2,512,250
PFEDodge & Cox 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 36.6722%Reduce -58.56%929,604
PFEKen Fisher 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 36.6722%Reduce -1.82%31,746,148
PFEMario Gabelli 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 36.6722%Reduce -24.04%537,011
PFET Rowe Price Equity Income Fund 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 36.6722%Add 1.42%14,730,900
PFEJohn Keeley 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 36.6722%Add 34.41%104,500
PFEDavid Dreman 2016-03-31 Buy 0.02%$28.56 - $32.28
($30.14)
$ 36.6722%New holding5,820
PFEBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce-0.01%$28.56 - $32.28
($30.14)
$ 36.6722%Reduce -0.26%53,724,766
PFEFirst Eagle Investment 2016-03-31 Add$28.56 - $32.28
($30.14)
$ 36.6722%Add 3.98%141,061
PFERichard Pzena 2016-03-31 Add$28.56 - $32.28
($30.14)
$ 36.6722%Add 1.18%2,187,104
PFERuane Cunniff 2016-03-31 Reduce$28.56 - $32.28
($30.14)
$ 36.6722%Reduce -16.22%12,442
PFELeon Cooperman 2015-12-31 Reduce-2.24%$31.33 - $35.45
($33.17)
$ 36.6711%Reduce -73.18%1,295,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.496.29view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.977.92view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.59.43view
YOUNG JOHN DGroup President 2016-05-10Sell41,700$33.539.33view
DAMELIO FRANK AExecutive Vice President 2016-05-10Sell192,000$33.668.91view
READ IAN CChairman & CEO 2016-05-09Sell275,000$33.88.46view
SUSMAN SALLYExecutive Vice President 2016-05-09Sell67,884$33.718.75view
HILL CHARLES HExecutive Vice President 2016-05-09Sell29,600$33.848.33view
MADDALUNA ANTHONY JExecutive Vice President 2016-05-09Sell8,950$33.758.62view
SUSMAN SALLYExecutive Vice President 2016-05-05Sell76,116$33.758.62view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Technology Earnings Helping Market to Gain Jul 20 2016 
    US Market Indexes Achieve New Highs Jul 14 2016 
    Investing in Big Pharma: Pointers on Pfizer Jul 14 2016 
    John Burbank's Best Investments Jul 14 2016 
    Investors Cautious in Trading as Stocks End Day Lower Jun 22 2016 
    U.S. Market Indexes Gain as Investors Await UK Vote Jun 21 2016 
    Pfizer, Merck, Other Big Pharmas Likely to Acquire Marijuana-Based Drug Companies Jun 13 2016 
    U.S. Stocks Trade Flat at Start of Week May 09 2016 
    UnitedHealth’s Obamacare Changes to Affect Healthcare Sector Apr 27 2016 
    Does Biotech’s Recent Bounce Have Legs? Apr 22 2016 

    More From Other Websites
    Jim Cramer: Second-Quarter Earnings Have Been Mixed Jul 28 2016
    [$$] Bristol-Myers Raises Yearly Outlook Jul 28 2016
    Pfizer And Western Oncolytics Reach Immuno-Oncology Research Collaboration Jul 28 2016
    Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel... Jul 28 2016
    Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel... Jul 28 2016
    AstraZeneca helped by new drugs as cholesterol pill fades Jul 28 2016
    AstraZeneca a takeover target again? CEO not commenting Jul 28 2016
    [$$] Specialty-Pharma Startup Nevakar Raises $55M Jul 27 2016
    Options Insight: Is Pfizer the Right Prescription? Jul 27 2016
    Options Insight: Is Pfizer the Right Prescription? Jul 27 2016
    [$$] Pfizer Cleared to Buy Nanotech Drug Firm Bind Therapeutics Jul 27 2016
    Pfizer Reaches Initial Deal Settling Celebrex, Bextra Suits Jul 27 2016
    Analyst Recommendations for Roche: Buy, Hold, or Sell? Jul 27 2016
    Short Sellers Get Selective on Major Pharma Jul 27 2016
    Bayer drugs secure earnings beat, offset weak crop chems Jul 27 2016
    Legislator: Pfizer can't complain about execution drug Jul 26 2016
    Legislator: Pfizer can't complain about execution drug Jul 26 2016
    BIND Therapeutics Determines Pfizer's $40 Million Bid Is Highest and Best in 363 Auction for... Jul 26 2016
    Jerome Dodson Comments on Allergan Jul 26 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)